A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
NCT ID: NCT06747949
Last Updated: 2026-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
844 participants
INTERVENTIONAL
2025-02-25
2029-12-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
NCT06104124
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State
NCT06245408
A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
NCT02614716
Tolerance and Efficacy of Rituximab in Sjogren's Disease
NCT00740948
Anti-CD20 Antibody Therapy for Sjogren's Syndrome
NCT00101829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dazodalibep
Participants who completed the 48-week dazodalibep or placebo treatment in trials HZNP-DAZ-301 or HZNP-DAZ-303 will receive assigned dose Dose A of dazodalibep for an additional 132 weeks.
Dazodalibep
Dazodalibep will be given intravenously (IV).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dazodalibep
Dazodalibep will be given intravenously (IV).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant has provided informed consent before initiation of any study specific activities/procedures.
* Must have been eligible to receive and have received IP (dazodalibep or placebo) and completed the study (through Week 48) in one of the phase 3 SS dazodalibep studies (HZNP-DAZ-301, or HZNP-DAZ-303).
* Must be able to receive Dose 1 of this LTE study at the Week 48 Visit (+28 days) for the prior pivotal phase 3 SS dazodalibep studies (HZNP DAZ-301, or HZNP DAZ-303).
Exclusion Criteria
* Clinically significant active infection at Day 1, in the opinion of the Investigator, including ongoing and chronic infection requiring antibiotics or antiviral medication.
* Planned participation in another clinical study with an IP or procedure during the LTE study. Other investigational procedures and participation in observational research studies while participating in this study are excluded.
* Any condition or change in health status observed or reported during the phase 3 SS studies (HZNP-DAZ-301, or HZNP-DAZ-303) that, in the opinion of the Investigator or the Sponsor, would interfere with evaluation and interpretation of participant safety or alter the risk-benefit associated with IP administration.
* Planned surgeries or hospitalizations that, in the opinion of the Investigator or the Sponsor, would interfere with evaluation and interpretation of participant safety.
* Individuals who plan to receive live (attenuated) vaccine during the LTE study.
* Female participants of childbearing potential unwilling to use protocol-specified method of contraception during treatment and for an additional 12 weeks after the last dose of investigational product.
* Female participants who are pregnant or lactating or planning to become pregnant during the study.
* Participant has known sensitivity to any of the products or components to be administered during dosing.
* Participant likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the participant and investigator's knowledge.
* History or evidence of any other clinically significant disorder, condition, or disease that, in the opinion of the investigator or Amgen physician, if consulted, would pose a risk to participant safety or interfere with the study evaluation.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amgen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MD
Role: STUDY_DIRECTOR
Amgen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BIOCINETIC Ltda
Santiago, , Chile
Polyclinic Bonifarm
Zagreb, City of Zagreb, Croatia
University Hospital of Split
Split, , Croatia
Arizona Arthritis & Rheumatology Associates - Avondale
Avondale, Arizona, United States
Arizona Arthritis and Rheumatology Associates - Flagstaff - 399 S Malpais Ln
Flagstaff, Arizona, United States
Arizona Arthritis and Rheumatology Associates - Gilbert - 3645 S Rome St
Gilbert, Arizona, United States
Arizona Arthritis and Rheumatology Associates - Glendale - 5681 W Beverly Ln
Glendale, Arizona, United States
Arizona Arthritis and Rheumatology Associates - Tucson - 2001 W Orange Grove Rd
Tucson, Arizona, United States
Samy Metyas MD Inc
Covina, California, United States
UCSD Altman Clinical and Translational Research Institute Building
La Jolla, California, United States
Tekton Research, LLC - 2121 E Harmony Rd - PPDS
Fort Collins, Colorado, United States
Bradenton Research Center Inc
Bradenton, Florida, United States
Clinical Research of West Florida Inc - Clearwater
Clearwater, Florida, United States
BayCare Medical Group Primary Care and Rheumatology - Tampa
Tampa, Florida, United States
Tufts University School of Dental Medicine
Boston, Massachusetts, United States
Shores Rheumatology
Saint Clair Shores, Michigan, United States
Kansas City Physician Partners-8350 N Saint Clair Ave
Kansas City, Missouri, United States
Arthritis, Rheumatic & Bone Disease Associates - P
Voorhees Township, New Jersey, United States
Duke Early Phase Clinical Research Unit - PPDS
Durham, North Carolina, United States
Onsite Clinical Solutions, LLC - Salisbury
Salisbury, North Carolina, United States
Arthritis & Osteoporosis Center of Southwest Ohio - Miamisburg
Miamisburg, Ohio, United States
University of Toledo Medical Center
Toledo, Ohio, United States
STAT Research-600 Aviator Ct
Vandalia, Ohio, United States
Accurate Clinical Management-Baytown
Baytown, Texas, United States
Precision Comprehensive Clinical Research Solutions
Colleyville, Texas, United States
R & H Clinical Research-777 S Fry Rd
Katy, Texas, United States
Houston Rheumatology & Arthritis Specialists - PLLC - PPDS
Katy, Texas, United States
Biopharma Informatic - Ridge Road - PPDS
McAllen, Texas, United States
Advanced Rheumatology of Houston
The Woodlands, Texas, United States
DM Clinical Research - Migraine and COPD - PPDS
Tomball, Texas, United States
Western Washington Medical Group, Bothell - Rheumatology
Bothell, Washington, United States
Rheumatology and Pulmonary Clinic
Beckley, West Virginia, United States
Consultorios Médicos Dr. Doreski - Fundacion Respirar - PPDS
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Instituto CER S.A.
Quilmes, Buenos Aires, Argentina
Instituto de Investigaciones Clinicas Quilmes SRL
Quilmes, Buenos Aires, Argentina
DOM Centro de Reumatología
Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina
Centro de Investigaciones Reumatológicas
San Miguel de Tucumán, Tucumán Province, Argentina
Centro Medico Privado de Reumatologia - PPDS
San Miguel de Tucumán, Tucumán Province, Argentina
Clínica Mayo de U.M.C.B. S.R.L
San Miguel de Tucumán, Tucumán Province, Argentina
Aprillus Asistencia e Investigacion - Terrada 89
Buenos Aires, , Argentina
Sanatorio Agote - Swiss Medical Group - PPDS
Buenos Aires, , Argentina
Sanatorio Allende S.A.-Hipolito Yrigoyen 384
Córdoba, , Argentina
Framingham Centro Médico
La Plata, , Argentina
Centro Polivalente de Asistencia e Investigación Clínica - CER San Juan
San Juan, , Argentina
The Queen Elizabeth Hospital
Woodville South, South Australia, Australia
UZ Gent
Ghent, , Belgium
SER - Serviços Especializados em Reumatologia da Bahia S/S - ME
Salvador, Estado de Bahia, Brazil
Centro de Estudos em Terapias Inovadoras
Curitiba, Paraná, Brazil
LMK Servicos Medicos SS
Porto Alegre, Rio Grande do Sul, Brazil
Clinique de Rhumatologie Du Centre Du Quebec
Trois-Rivières, Quebec, Canada
Centro de Investigacion de Enfermedades Respiratorias e inmunologicas
Viña del Mar, Región de Valparaíso, Chile
Enroll SpA - Dr. Manuel Barros Borgono - PPDS
Providencia, , Chile
CHU de Bordeaux - Hôpital Saint-André
Bordeaux, , France
CHU de Brest - Hôpital La Cavale Blanche
Brest, , France
GHRMSA - Hôpital Emile Muller
Mulhouse, , France
AP-HP - Hôpital Saint Antoine
Paris, , France
Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
University Clinic Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
Rheumazentrum Prof. Dr. med. Gunther Neeck-Standort Bad Doberan
Bad Doberan, Mecklenburg-Vorpommern, Germany
Rheumazentrum Greifswald
Greifswald Hansestadt, Mecklenburg-Vorpommern, Germany
MVZ Rheuma
Hamburg, , Germany
University General Hospital of Larissa
Larissa, Larisa, Greece
Euromedica Kianous Stavros
Thessaloniki, , Greece
Bekes Varmegyei Kozponti Korhaz
Gyula, Bekes County, Hungary
Vasarhelyi Sarkanyfu Kft.
Hódmezovásárhely, Csongrád megye, Hungary
Debreceni Egyetem Klinikai Kozpont Nagyerdei Campus
Debrecen, Hajdú-Bihar, Hungary
Del-pesti Centrumkorhaz- Orszagos Hematologiai és Infektologiai Intezet - Albert Flórián út 5-7
Budapest, , Hungary
Meir Medical Center
Kafr Saba, Central District, Israel
The Chaim Sheba Medical Center - PPDS
Ramat Gan, Tel Aviv, Israel
Fondazione Policlinico Universitario Campus Bio-Medico
Rome, Lazio, Italy
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Lombardy, Italy
Azienda Ospedaliera Universitaria Integrata Di Verona
Verona, Veneto, Italy
Azienda Ospedaliero Universitaria Pisana - Stabilimento Santa Chiara
Pisa, , Italy
AUSL di Reggio Emilia - IRCCS - Arcispedale Santa Maria Nuova
Reggio Emilia, , Italy
Chubu Rosai Hospital
Nagoya-shi, Akita, Japan
Japan Community Health Care Organization (JCHO) Chukyo Hospital
Nagoya-shi, Akita, Japan
Hospital of the University of Occupational and Environmental Health, Japan
Kita Kyushu-shi, Hukuoka, Japan
University of Tsukuba Hospital
Tsukuba, Ibaraki, Japan
Kanazawa Medical University Hospital
Kahoku, Ishikawa-ken, Japan
National Hospital Organization Yokohama Medical Center
Yokohama, Kanagawa, Japan
University Hospital, Kyoto Prefectural University of Medicine
Kyoto, Kyôto, Japan
Kyoto University Hospital
Kyoto, Kyôto, Japan
Kurashiki Medical Clinic
Kurashiki-Shi, Okayama-ken, Japan
Saitama Medical University Hospital
Iruma-Gun Moroyama-Machi, Saitama, Japan
Hamamatsu University Hospital
Hamamatsu, Shizuoka, Japan
St. Luke's International Hospital
Chuo-Ku, Tokyo, Japan
Tokyo Medical Center
Meguro-Ku, Tokyo, Japan
Mediadvance Clinical S.A.P.I. de C.V.
Parques de San Felipe, Chihuahua, Mexico
Clinstile, S.A. de C.V.
Mexico City, , Mexico
Optimal Clinical Trials Ltd - PPDS
Auckland, North Island, New Zealand
Health New Zealand - Te Whatu Ora - Waikato (Waikato Hospital)
Hamilton, , New Zealand
Aotearoa Clinical Trials Trust- Middlemore Hospital
Papatoetoe, , New Zealand
Med-Polonia Sp. z o.o.
Poznan, Greater Poland Voivodeship, Poland
Malopolskie Centrum Kliniczne
Krakow, Lesser Poland Voivodeship, Poland
Centrum Medyczne Oporow
Wroclaw, Lower Silesian Voivodeship, Poland
ETG Lublin - PPDS
Lublin, Lublin Voivodeship, Poland
Zespol Poradni Specjalistycznych REUMED- Wallenroda 2F/4
Lublin, Lublin Voivodeship, Poland
MICS Centrum Medyczne Warszawa - MICS - PPDS
Warsaw, Masovian Voivodeship, Poland
MTZ Clinical Research Powered by PRATIA - PPDS
Warsaw, Masovian Voivodeship, Poland
ARS RHEUMATICA Sp. z o.o.
Warsaw, Masovian Voivodeship, Poland
WIM-PIB, Centralny Szpital Kliniczny MON
Warsaw, Masovian Voivodeship, Poland
Centrum Medyczne K2J2 - Wołomin
Wołomin, Masovian Voivodeship, Poland
Centrum Badawcze Panaceum Agnieszka Brzezicka Magdalena Lenkiewicz Sp. Z o.o.
Malbork, Pomeranian Voivodeship, Poland
MICS Centrum Medyczne Bydgoszcz
Bydgoszcz, , Poland
Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy
Bydgoszcz, , Poland
Centrum Medyczne Pratia Katowice - PPDS
Katowice, , Poland
Centrum Medyczne Plejady Magdalena Celinska - Lowenhoff, Michal Zolnowski Spolka komandytowa
Krakow, , Poland
FutureMeds - Lodz - PPDS
Lodz, , Poland
Twoja Przychodnia PCM
Poznan, , Poland
FutureMeds - Warszawa Centrum - PPDS
Warsaw, , Poland
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. Prof. Dr hab. Med. Eleonory Reicher
Warsaw, , Poland
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu - Borowska 213
Wroclaw, , Poland
Pracownia Badan Klinicznych Salus - ul. Ołtaszyńska 92c/3
Wroclaw, , Poland
FutureMeds - Wroclaw - PPDS
Wroclaw, , Poland
ULS de Lisboa Ocidental, EPE - Hospital Egas Moniz
Lisbon, Lisbon District, Portugal
ULS de Santa Maria,EPE - Hospital de Santa Maria - PPDS
Lisbon, Lisbon District, Portugal
Hospital Conde de Bertiandos - Unidade Local de saúde do Alto Minho, EPE - Ponte de Lima
Ponte de Lima, , Portugal
ULS de Gaia/Espinho, EPE - Unidade I
Vila Nova de Gaia, , Portugal
Military Medical Academy
Belgrade, Belgrade, Serbia
Institute of Rheumatology - PPDS
Belgrade, , Serbia
Klinika za Alergologiju i Imunologiju
Belgrade, , Serbia
University Clinical Center Kragujevac
Kragujevac, , Serbia
Clinical Centre of Vojvodina
Novi Sad, , Serbia
The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, Seoul Teugbyeolsi, South Korea
Fundacio Hospital de l'Esperit Sant
Santa Coloma de Gramenet, Barcelona, Spain
C.H. Regional Reina Sofia - PPDS
Córdoba, Córdoba, Spain
Hospital Universitario de Basurto
Bilbao, Vizcaya, Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Hospital Quironsalud Infanta Luisa
Seville, , Spain
Hospital Universitario de Valme
Seville, , Spain
Kaohsiung Medical University - Chung-Ho Memorial Hospital
Kaohsiung City, , Taiwan
Taichung Veterans General Hospital
Taichung, , Taiwan
Chang Gung Memorial Hospital, Linkou
Taoyuan District, , Taiwan
Chapel Allerton Hospital - PPDS
Leeds, , United Kingdom
Mile End Hospital - PPDS
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
AmgenTrials clinical trials website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20230050
Identifier Type: OTHER
Identifier Source: secondary_id
2024-517513-32-00
Identifier Type: OTHER
Identifier Source: secondary_id
HZNP-DAZ-304
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.